Stock listing
OTC:RICFY Recordati S.p.A. Stock
US listing (OTC) of Recordati S.p.A. · home listing Milan:REC
Follow Recordati S.p.A. into a list and get an email when it puts out news.
Share price · OTC:RICFY
$14.65 USD 0.00 (0.0%)
Close on Nov 20, 2026
- Day range
- $14.65 – $14.65 USDNov 20, 2026
- Volume
- 230 sharesNov 20, 2026
- Market cap
- $12.19B USDAt the close on Nov 20, 2026 · price × 832.0M shares outstanding
- 52-week range
- $9.29 – $17.16 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $6,686 USDMedian day 199 shares · 26 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| OTC:RICFY | $14.65 USD | 0.00 (0.0%) | 230 | $14.65 | $14.65 | $14.65 | $14.65 | Close on Nov 20, 2026 |
| Frankfurt:RER1 | €52.70 EUR | -0.05 (-0.1%) | — | €52.55 | €52.75 | €52.55 | €52.75 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:RICFY · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $14.65 | 0.00 | 0.0% | $14.65 | $14.65 | $14.65 | 230 | |
| $14.65 | +0.094 | +0.6% | $13.19 | $14.65 | $10.52 | 1,322 | |
| $14.56 | 0.00 | 0.0% | $14.56 | $14.56 | $14.56 | 0 | |
| $14.56 | +0.036 | +0.2% | $14.06 | $14.56 | $14.06 | 1,230 | |
| $14.52 | +0.12 | +0.8% | $14.52 | $14.52 | $14.52 | 284 | |
| $14.40 | -0.08 | -0.6% | $14.40 | $14.40 | $14.40 | 147 | |
| $14.48 | +0.37 | +2.6% | $14.48 | $14.48 | $14.48 | 828 | |
| $14.11 | -0.02 | -0.1% | $14.11 | $14.11 | $14.11 | 285 | |
| $14.13 | -1.83 | -11.5% | $15.28 | $15.28 | $14.13 | 582 | |
| $15.96 | +1.64 | +11.5% | $15.96 | $15.96 | $15.96 | 654 | |
| $14.32 | -0.505 | -3.4% | $14.75 | $14.79 | $14.32 | 2,418 | |
| $14.83 | +0.325 | +2.2% | $14.78 | $14.85 | $14.73 | 2,764 | |
| $14.50 | -0.43 | -2.9% | $14.50 | $14.50 | $14.50 | 929 | |
| $14.93 | 0.00 | 0.0% | $14.93 | $14.93 | $14.93 | 0 | |
| $14.93 | +2.46 | +19.7% | $14.71 | $14.93 | $14.69 | 1,163 | |
| $12.47 | 0.00 | 0.0% | $12.47 | $12.47 | $12.47 | 0 | |
| $12.47 | -2.53 | -16.9% | $14.54 | $14.54 | $12.45 | 658 | |
| $15.00 | +0.895 | +6.3% | $15.00 | $15.00 | $15.00 | 180 | |
| $14.11 | +0.513 | +3.8% | $14.11 | $14.11 | $14.11 | 455 | |
| $13.59 | -0.962 | -6.6% | $14.13 | $14.13 | $13.59 | 1,386 | |
| $14.55 | +0.217 | +1.5% | $13.28 | $14.55 | $13.28 | 626 | |
| $14.34 | +1.917 | +15.4% | $14.22 | $14.34 | $14.22 | 1,500 | |
| $12.42 | 0.00 | 0.0% | $12.42 | $12.42 | $12.42 | 0 | |
| $12.42 | -2.185 | -15.0% | $14.61 | $14.61 | $12.42 | 487 | |
| $14.61 | -0.395 | -2.6% | $14.61 | $14.61 | $14.61 | 640 | |
| $15.00 | -0.644 | -4.1% | $14.61 | $16.79 | $14.61 | 1,841 | |
| $15.64 | 0.00 | 0.0% | $15.64 | $15.64 | $15.64 | 309 | |
| $15.64 | 0.00 | 0.0% | $15.64 | $15.64 | $15.64 | 0 | |
| $15.64 | +0.558 | +3.7% | $15.64 | $15.64 | $15.64 | 2,014 | |
| $15.09 | 0.00 | 0.0% | $15.09 | $15.09 | $15.09 | 0 | |
| $15.09 | -0.034 | -0.2% | $14.48 | $15.09 | $14.48 | 454 | |
| $15.12 | 0.00 | 0.0% | $15.12 | $15.12 | $15.12 | 0 | |
| $15.12 | 0.00 | 0.0% | $15.12 | $15.12 | $15.12 | 0 | |
| $15.12 | 0.00 | 0.0% | $15.12 | $15.12 | $15.12 | 0 | |
| $15.12 | 0.00 | 0.0% | $15.12 | $15.12 | $15.12 | 0 | |
| $15.12 | 0.00 | 0.0% | $15.12 | $15.12 | $15.12 | 0 | |
| $15.12 | +0.315 | +2.1% | $15.12 | $15.12 | $15.12 | 311 | |
| $14.81 | +0.719 | +5.1% | $14.81 | $14.81 | $14.81 | 194 | |
| $14.09 | 0.00 | 0.0% | $14.09 | $14.09 | $14.09 | 0 | |
| $14.09 | -1.134 | -7.4% | $14.09 | $14.09 | $14.09 | 1,383 | |
| $15.22 | 0.00 | 0.0% | $15.22 | $15.22 | $15.22 | 0 | |
| $15.22 | +0.38 | +2.6% | $15.22 | $15.22 | $15.22 | 231 | |
| $14.84 | +0.01 | +0.1% | $14.84 | $14.84 | $14.84 | 199 | |
| $14.83 | 0.00 | 0.0% | $14.83 | $14.83 | $14.83 | 0 | |
| $14.83 | 0.00 | 0.0% | $14.83 | $14.83 | $14.83 | 0 | |
| $14.83 | -0.92 | -5.8% | $14.83 | $14.83 | $14.83 | 161 | |
| $15.75 | 0.00 | 0.0% | $15.75 | $15.75 | $15.75 | 0 | |
| $15.75 | +0.695 | +4.6% | $15.75 | $15.75 | $15.75 | 1,003 | |
| $15.06 | 0.00 | 0.0% | $15.06 | $15.06 | $15.06 | 0 | |
| $15.06 | 0.00 | 0.0% | $15.06 | $15.06 | $15.06 | 0 | |
| $15.06 | 0.00 | 0.0% | $15.06 | $15.06 | $15.06 | 0 | |
| $15.06 | 0.00 | 0.0% | $15.06 | $15.06 | $15.06 | 0 | |
| $15.06 | 0.00 | 0.0% | $15.06 | $15.06 | $15.06 | 146 | |
| $15.06 | -0.135 | -0.9% | $15.06 | $15.06 | $15.06 | 315 | |
| $15.19 | 0.00 | 0.0% | $13.21 | $15.19 | $13.21 | 146 | |
| $15.19 | 0.00 | 0.0% | $15.19 | $15.19 | $15.19 | 0 | |
| $15.19 | 0.00 | 0.0% | $15.19 | $15.19 | $15.19 | 0 | |
| $15.19 | 0.00 | 0.0% | $15.19 | $15.19 | $15.19 | 0 | |
| $15.19 | 0.00 | 0.0% | $15.19 | $15.19 | $15.19 | 0 | |
| $15.19 | +1.42 | +10.3% | $15.18 | $15.19 | $15.18 | 748 | |
| $13.77 | -0.84 | -5.7% | $13.77 | $13.77 | $13.77 | 274 | |
| $14.61 | +1.69 | +13.1% | $14.61 | $14.61 | $14.61 | 274 | |
| $12.92 | -2.26 | -14.9% | $12.92 | $12.92 | $12.92 | 1,579 | |
| $15.18 | +0.015 | +0.1% | $15.18 | $15.18 | $15.18 | 135 | |
| $15.17 | -0.06 | -0.4% | $15.17 | $15.17 | $15.17 | 301 | |
| $15.23 | 0.00 | 0.0% | $15.23 | $15.23 | $15.23 | 0 | |
| $15.23 | 0.00 | 0.0% | $15.23 | $15.23 | $15.23 | 0 |
- Ticker
- OTC:RICFY
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- OTC
- Currency
- USD
What changed lately
Latest news release · Nov 10, 2026
Recordati first nine months 2026: net revenue +7.5%, EBITDA +7.7%, Adjusted net income +6.4%
Latest earnings call · Jul 29, 2026
Recordati (Milan:REC) Q2 2026 Earnings Call
Replay and transcript
Latest deck · Nov 10, 2026
9M 2026 Earnings Presentation
Earnings · 17 slides
Latest news
Recordati first nine months 2026: net revenue +7.5%, EBITDA +7.7%, Adjusted net income +6.4%
Nov 10, 2026
Closed $14.13 (-11.5%) on Nov 10, 2026
Recordati announces the winner of the 12th edition of the Arrigo Recordati Prize for scientific research
Sep 17, 2026
Closed $15.75 (0.0%) on Sep 17, 2026
Palliser Capital Issues Letter to Recordati’s Board of Directors Urging Withdrawal of Support on Materially Undervalued Tender Offer
Sep 14, 2026
Closed $15.06 (0.0%) on Sep 14, 2026
Recordati: solid momentum of the group continues first half 2026. net revenue +6.6%, EBITDA +8.8%, Adjusted Net income +6.7%
Jul 28, 2026
Closed $13.21 (-10.8%) on Jul 28, 2026
Recordati celebrates its first 100 years at triennale milano with an exhibition revealing objects and images from its historical archive for the first time
Jun 16, 2026
Closed $14.96 (0.0%) on Jun 16, 2026
First Quarter Report 2026
May 14, 2026
Closed $12.68 (0.0%) on May 14, 2026
Recordati: strong momentum of the group continues into the first quarter of 2026 net revenue +4.9%, EBITDA(1) +5.0%, Adjusted net income(2) +7.2%
May 12, 2026
Closed $12.68 (0.0%) on May 12, 2026
1 April 2026 - Financial Statements of Recordati S.p.A. at 31 December 2025 and related Report of the Auditing Firm
Apr 1, 2026
Closed $11.64 (0.0%) on Apr 1, 2026
Recordati reports strong preliminary full year 2025 results: revenue +11.8%, EBITDA(1) +14.5%, Adjusted net income(2) +14.5%
Feb 17, 2026
Closed $13.64 (0.0%) on Feb 17, 2026
Recordati reports strong preliminary full year 2025 results: revenue 11.8%, EBITDA 14.5%, Adjusted net income 14.5%
Feb 17, 2026
Closed $13.64 (0.0%) on Feb 17, 2026
Recordati S.p.A. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 12 in the last 12 months · 15 in all · newest Nov 10, 2026 · oldest 2025
- Calls
- 22 calls with a replay · 22 with a transcript · latest Jul 29, 2026
- Decks
- 162 decks · latest Nov 10, 2026
Where Recordati S.p.A. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| Milan:REC · Home listing | Milan | Italy | EUR |
| OTC:RICFY · This page | OTC | United States | USD |
| gettex:RER1 | gettex | Germany | EUR |
| VIE:REC | Vienna | Austria | EUR |
| OTC:RCDTF | OTC | United States | USD |
| Tradegate:RER1 | Tradegate | Germany | EUR |
| LS Exchange:A0EABR | LS Exchange | Germany | EUR |
| Turquoise:RECM | Turquoise | United Kingdom | EUR |
| Lang & Schwarz:A0EABR | Lang & Schwarz | Germany | EUR |
| LSIN:0KBS | LSIN | United Kingdom | EUR |
| Aquis:RECM | Aquis | United Kingdom | EUR |
| BMV:RECN | BMV | Mexico | MXN |
| Aquis:RECM | Aquis | United Kingdom | EUR |
| Stuttgart:RER1 | Stuttgart | Germany | EUR |
| Frankfurt:RER1 | Frankfurt | Germany | EUR |
| Hanover:RER1 | Hanover | Germany | EUR |
| BIVA:RECN | BIVA | Mexico | MXN |
| Dusseldorf:RER1 | Dusseldorf | Germany | EUR |
| Hamburg:RER1 | Hamburg | Germany | EUR |
| Munich:RER1 | Munich | Germany | EUR |
Team and board
Officers
| Officer | Role |
|---|---|
| Robert Koremans | Chief Executive Officer |
| Mike McClellan | Chief Financial Officer |
| Bibianne Bon | Group Chief Legal Officer |
| Silvia Signoretti | Group Corporate Law Counsel and Secretary of the Board of Directors of Recordati S.p.A |
| Eugenia Litz | Investor Relations |
| Alberto Martinez | Executive VP Specialty & Primary Care Business Unit |
| Alessandro Gilio | Executive VP Group Industrial Operations |
| Gabriele Finzi | Executive VP Corporate Development, Licensing & Innovation |
| Milan Zdravkovic | Executive VP Research & Development and Chief Medical Officer |
| Scott Pescatore | Executive VP Rare Diseases Business Unit |
| Alessandra Abate | Group Chief People and Culture Officer |
Board
| Director | Role |
|---|---|
| Andrea Recordati | Presidente |
| Cathrin Petty | |
| Diva Moriani | Indipendente e Lid |
| Giampiero Mazza | |
| Joanna Le Couilliard | Indipendente |
| Kim Stratton | |
| Luigi La Corte | |
| Piergiorgio Peluso | Indipendente |
| Robert Koremans | Chief Executive Officer |
| Stephen Sands | Indipendente |
Events
| Call | When | Status |
|---|---|---|
| Recordati (Milan:REC) Q2 2026 Earnings Call | Wed, Jul 29, 2026 · 8:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2026 Earnings Call | Wed, May 13, 2026 · 8:00 AM ET | Replay |
| Recordati (Milan:REC) Q4 2025 Earnings Call | Wed, Feb 18, 2026 · 8:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2025 Earnings Call | Wed, Nov 12, 2025 · 8:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2025 Earnings Call | Wed, Jul 30, 2025 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2024 Earnings Call | Fri, Nov 08, 2024 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2024 Earnings Call | Tue, Jul 30, 2024 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2023 Earnings Call | Tue, Nov 07, 2023 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2023 Earnings Call | Fri, Jul 28, 2023 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2023 Earnings Call | Thu, May 11, 2023 · 11:00 AM ET | Replay |
All 22 calls
| Call | When | Status |
|---|---|---|
| Recordati (Milan:REC) Q4 2022 Earnings Call | Tue, Feb 21, 2023 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2022 Earnings Call | Tue, Nov 08, 2022 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2022 Earnings Call | Thu, Jul 28, 2022 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2022 Earnings Call | Tue, May 10, 2022 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q4 2021 Earnings Call | Thu, Feb 24, 2022 · 9:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2021 Earnings Call | Thu, Oct 28, 2021 · 9:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2021 Earnings Call | Thu, Jul 29, 2021 · 9:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2021 Earnings Call | Thu, May 06, 2021 · 9:00 AM ET | Replay |
| Recordati (Milan:REC) Q4 2020 Earnings Call | Mon, Feb 22, 2021 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q3 2020 Earnings Call | Fri, Oct 30, 2020 · 11:00 AM ET | Replay |
| Recordati (Milan:REC) Q2 2020 Earnings Call | Thu, Jul 30, 2020 · 10:00 AM ET | Replay |
| Recordati (Milan:REC) Q1 2020 Earnings Call | Thu, May 07, 2020 · 10:00 AM ET | Replay |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| 9M 2026 Earnings Presentation | Earnings | 17 slides | Nov 10, 2026 |
| Recordati Industria Chimica e Farmaceutica — H1 2026 Earnings Presentation | Earnings | 22 slides | Jul 29, 2026 |
| Recordati Industria Chimica e Farmaceutica — Q1 2026 Earnings Presentation | Earnings | 25 slides | May 13, 2026 |
| Recordati Industria Chimica e Farmaceutica — FY2025 Earnings Presentation | Earnings | 25 slides | Feb 18, 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 13 slides | Jan 14, 2026 |
| Recordati Industria Chimica e Farmaceutica — Q3 2025 Earnings Presentation | Earnings | 24 slides | Nov 12, 2025 |
| Recordati Industria Chimica e Farmaceutica — H1 2025 Earnings Presentation | Earnings | 21 slides | Jul 30, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 21 slides | May 8, 2025 |
| Investor Day (April 2025) | Investor day | 45 slides | Apr 29, 2025 |
| FY2024 Earnings Presentation | Earnings | 23 slides | Feb 13, 2025 |
Show 50 decks
This page holds 50 of 162 decks. Open Decks
Financials
Annual, in EUR
Balance sheet
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Cash and equivalents | 322.4M | 221.8M | 284.7M | 244.6M |
| Receivables | 361.9M | 307.8M | ||
| Current assets | 1.49B | 1.20B | 1.17B | 850.1M |
| Goodwill | 797.1M | 778.4M | 780.1M | 553.2M |
| Total assets | 5.13B | 4.21B | 4.00B | 2.82B |
| Accounts payable | 296.7M | 264.0M | 224.7M | 177.9M |
| Current liabilities | 929.1M | 1.00B | 923.7M | 626.4M |
| Shareholders' equity | 1.88B | 1.69B | 1.55B | 1.38B |
Cash flow
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Dividends paid | -130.1M | -123.2M | -117.2M | -113.0M |
Cap table
Built by 6ix from Recordati S.p.A.’s releases
- Common shares
- 209,125,156
- Fully diluted
- 209,125,156
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 209,125,156 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 209,125,156 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Alberto Martinez | Executive VP Specialty & Primary Care Business Unit · Since at least Nov 4, 2026 |
| Alessandra Abate | Group Chief People and Culture Officer · Since at least Nov 5, 2026 |
| Alessandro Gilio | Executive VP Group Industrial Operations · Since at least Nov 5, 2026 |
| Andrea Recordati | Presidente · Since at least Sep 17, 2026 |
| Bibianne Bon | Group Chief Legal Officer · Since at least Nov 5, 2026 |
| Cathrin Petty | Director · Since at least Apr 1, 2026 |
| Diva Moriani | Indipendente e Lid · Since at least Apr 1, 2026 |
| Eugenia Litz | Investor Relations · Since at least Jul 28, 2026 |
| Gabriele Finzi | Executive VP Corporate Development, Licensing & Innovation · Since at least Nov 5, 2026 |
| Giampiero Mazza | Director · Since at least Apr 1, 2026 |
All 20 people
| Person | Seat |
|---|---|
| Joanna Le Couilliard | Indipendente · Since at least Apr 1, 2026 |
| Kim Stratton | Director · Since at least Apr 1, 2026 |
| Luigi La Corte | Director · Since at least Apr 1, 2026 |
| Mike McClellan | Chief Financial Officer · Since at least Oct 23, 2025 |
| Milan Zdravkovic | Executive VP Research & Development and Chief Medical Officer · Since at least Nov 5, 2026 |
| Piergiorgio Peluso | Indipendente · Since at least Apr 1, 2026 |
| Robert Koremans | Chief Executive Officer · Since at least May 14, 2026 |
| Scott Pescatore | Executive VP Rare Diseases Business Unit · Since at least Nov 4, 2026 |
| Silvia Signoretti | Group Corporate Law Counsel and Secretary of the Board of Directors of Recordati S.p.A · Since at least Nov 5, 2026 |
| Stephen Sands | Indipendente · Since at least Apr 1, 2026 |
Log in to ask 6ix AI your own questions about Recordati S.p.A.